What is the natural history of rheumatoid arthritis

作者: William E.R Ollier , Beverley Harrison , Deborah Symmons

DOI: 10.1053/BERH.2000.0124

关键词:

摘要: Inflammatory polyarthritis can be a self-limiting disease, develop into rheumatoid arthritis (RA) or differentiate another form of chronic arthritis. It remains clinical and scientific challenge to understand the relationship between these phenotypes, determine their aetiologies predict course outcome for individual patients. Even patients labelled as having RA show wide spectrum phenotypes. Disease definition is major problem in studying aetiology currently used classification criteria were derived using with established disease. thought result from combination genetic susceptibility exposure an appropriate environmental trigger. The component probably oligogenic. association HLA has been known over 25 years. now associated conserved sequence amino acids number HLA-DRB1 alleles, called shared epitope. However, epitope appears chronicity severity more than susceptibility. Other potential genes include IL-1, aromatase, corticotropin-releasing hormone region on X chromosome. Hormonal reproductive factors also influence severity. common women men, especially before menopause. Men may protected by hormonal require stronger Although infectious triggers have long suspected, no definitive evidence obtained. Previous blood transfusion, smoking obesity are possible risk factors. Chronicity remission important aspects natural history early RA. we identify at adverse prognosis some accuracy, remain unable remission. Functional disability radiological damage most studied outcomes Radiological often occurs RA, but erosion first time several years after symptom onset. Many studies demonstrated features severe This related gene dosage.

参考文章(74)
Dugowson Ce, Voigt Lf, Koepsell Td, Daling, Nelson Jl, Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology. ,vol. 5, pp. 525- 532 ,(1994)
Peltomaa R, Paimela L, Leirisalo-Repo M, Helve T, Effect of age on 3 year outcome in early rheumatoid arthritis The Journal of Rheumatology. ,vol. 27, pp. 638- 643 ,(2000)
Aho K, Isomäki H, Laakso M, Kaipiainen-Seppänen O, Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990. Clinical and Experimental Rheumatology. ,vol. 14, pp. 537- 542 ,(1996)
Eberhardt Kb, Fex E, Functional impairment and disability in early rheumatoid arthritis--development over 5 years. The Journal of Rheumatology. ,vol. 22, pp. 1037- 1042 ,(1995)
Kvien Tk, Moum T, Smedstad Lm, Vaglum P, Life events, psychosocial factors, and demographic variables in early rheumatoid arthritis: relations to one-year changes in functional disability. The Journal of Rheumatology. ,vol. 22, pp. 2218- 2225 ,(1995)
Trang L, Borg G, Pettersson H, Lund B, Brodin U, Egsmose C, Berg E, Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. The Journal of Rheumatology. ,vol. 22, pp. 2208- 2213 ,(1995)
F Wolfe, The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. The Journal of Rheumatology. ,vol. 27, pp. 630- 637 ,(2000)
van Riel Pl, van 't Hof M, van de Putte Lb, van der Heijde Dm, Development of a disease activity score based on judgment in clinical practice by rheumatologists The Journal of Rheumatology. ,vol. 20, pp. 579- 581 ,(1993)
David A. Isernberg, Lori B. Tucker, Controversies in Rheumatology ,(1997)
Agnes van der Heide, The Effectiveness of Early Treatment with “Second-Line” Antirheumatic Drugs Annals of Internal Medicine. ,vol. 124, pp. 699- 707 ,(1996) , 10.7326/0003-4819-124-8-199604150-00001